Animal Models & Clinical Trials

Animals are still used in research in order to create vaccines for humans. Before being allowed to proceed to the clinical stage in human beings, regulatory bodies mandate that innovative vaccination candidates go through preclinical evaluation in animal models. The number of animals utilized for preclinical vaccine research has been steadily declining in recent years thanks to advances in computational biology and bioinformatics for the creation of novel vaccine candidates. However, the ultimate objective of a novel vaccination is to direct the immune system to mount a successful defense  against the pathogen of interest, and at this point, there are no substitutes for using live animals in the assessment of this defense.

 

    Related Conference of Animal Models & Clinical Trials

    May 30-31, 2024

    World congress on Immunology and Virology Diseases

    Vienna, Austria
    August 01-02, 2024

    44th Global Summit and Expo on Vaccines & Immunology

    Montreal, Canada
    September 09-10, 2024

    4th International Conference on Vaccine Research

    Madrid, Spain
    September 09-10, 2024

    7th International Conference on Vaccines and Immunology

    Madrid, Spain
    November 28-29, 2024

    6th World Congress on Vaccine and Immunology

    Paris, France

    Animal Models & Clinical Trials Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in